CALLEGARI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 2.451
EU - Europa 588
AS - Asia 299
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.344
Nazione #
US - Stati Uniti d'America 2.450
CN - Cina 228
PL - Polonia 149
IT - Italia 146
UA - Ucraina 92
GB - Regno Unito 59
TR - Turchia 53
DE - Germania 52
SE - Svezia 24
FI - Finlandia 21
RO - Romania 19
BE - Belgio 11
VN - Vietnam 8
GR - Grecia 6
IN - India 6
BR - Brasile 5
FR - Francia 2
IR - Iran 2
NL - Olanda 2
BG - Bulgaria 1
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EU - Europa 1
JP - Giappone 1
RS - Serbia 1
RU - Federazione Russa 1
UZ - Uzbekistan 1
Totale 3.344
Città #
Fairfield 456
Woodbridge 260
Ashburn 223
Houston 209
Seattle 159
Warsaw 148
Wilmington 145
Chandler 144
Ann Arbor 139
Cambridge 135
Jacksonville 108
Beijing 63
Ferrara 50
New York 46
Nanjing 41
Izmir 39
Milan 35
San Diego 34
Princeton 33
Shanghai 28
Nanchang 20
Jinan 18
Boardman 17
Timisoara 17
Bologna 12
Addison 10
Dearborn 10
London 10
Los Angeles 10
Shenyang 10
Brussels 9
Dong Ket 8
Falls Church 8
Mountain View 8
Washington 8
Hangzhou 7
Hebei 6
Auburn Hills 5
Berkeley 5
Changsha 5
Des Moines 5
Jiaxing 5
Leeds 5
Ningbo 5
Tallahassee 5
Bremen 4
Hefei 4
Norwalk 4
Redwood City 4
Thessaloníki 4
Zhengzhou 4
Chicago 3
Guangzhou 3
Kunming 3
Rome 3
San Giorgio Di Piano 3
San Mateo 3
Tappahannock 3
Ardabil 2
Augusta 2
Dekalb 2
Ferrara di Monte Baldo 2
Focsani 2
Helsinki 2
Istanbul 2
Manchester 2
Monte San Pietro 2
Patras 2
Prescot 2
Redmond 2
Stony Brook 2
Waanrode 2
Walnut 2
Acton 1
Belgrade 1
Cassano Magnago 1
Chengdu 1
College Station 1
Duncan 1
Hanover 1
Hounslow 1
Indiana 1
Kilburn 1
La Jolla 1
Lanzhou 1
Leawood 1
Monmouth Junction 1
Padova 1
Pavullo Nel Frignano 1
Philadelphia 1
Prague 1
Pune 1
Saint Louis 1
San Francisco 1
Shenzhen 1
Sofia 1
Southend 1
Taizhou 1
Tokyo 1
Toronto 1
Totale 2.825
Nome #
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 285
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 171
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 142
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 141
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 140
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 138
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 138
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 131
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 128
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 128
MicroRNA involvement in hepatocellular carcinoma 124
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 117
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 115
MicroRNA response to environmental mutagens in liver 110
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. 108
null 107
Animal Models of Hepatocellular Carcinoma Prevention 104
null 103
Associations of risk factors obesity and occupational airborne exposures with CDKN2A/p16 aberrant DNA methylation in esophageal cancer patients 95
Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma 94
null 89
Quantification of Circulating miRNAs by Droplet Digital PCR: Comparison of EvaGreen- and TaqMan-Based Chemistries. 89
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 84
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 81
Emerging role of microRNAs in the treatment of hepatocellular carcinoma 72
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 70
null 63
MicroRNAs in Animal Models of HCC 61
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 49
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 41
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 26
Erratum: miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 20
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA 19
Novel Virus Identification through Metagenomics: A Systematic Review 17
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 15
Role of microRNAs in hepatocellular carcinoma: a clinical perspective 12
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 12
Totale 3.439
Categoria #
all - tutte 10.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019366 0 0 0 0 0 0 0 0 32 75 103 156
2019/2020900 94 26 26 121 61 101 100 103 88 90 52 38
2020/2021781 55 70 141 59 40 58 25 61 21 145 54 52
2021/2022399 13 38 52 18 10 29 22 22 17 25 40 113
2022/2023348 32 19 19 46 47 42 41 26 42 0 21 13
2023/2024233 15 36 15 6 28 77 11 39 6 0 0 0
Totale 3.439